Business
MOU with Swansea University
MOU with Swansea University.
About this update from Physiomics Plc
[{"type":"text","content":"\n Physiomics PLC\n17 December 2007\n\n\n Physiomics plc\n The Magdalen Centre\n The Oxford Science Park\n Robert Robinson Avenue\n Oxford\n OX4 4GA\n UK\n\n Tel 01865 784980\n Fax 08701 671931\n\n\n17 December 2007\n\n\n Physiomics Plc\n\n ('Physiomics' or 'the Company')\n\n\nMOU with Swansea University (access to Supercomputer 'Blue C')\n\nPhysiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is\npleased to announce that it has signed a Memorandum of Understanding ('MOU')\nwith the Institute of Life Science of Swansea University ('ILS'), which will\nprovide mutual benefits.\n\nUnder the terms of the MOU, Physiomics will have access to the Supercomputer\n'Blue C', one of the most powerful computers in the world dedicated to Life\nScience and is the result of a collaboration between the University, the Welsh\nAssembly Government and computer giant IBM. This will reinforce Physiomics'\nmodelling framework and help to address the ever increasing computing\nrequirements in the field of System Biology.\n\nCollaborative research programs will be set up with the oncology research groups\nat the ILS, with the first collaboration already agreed with the group of Dr\nShareen Doak. These programs will focus on the effect of anticancer drugs and\nPhysiomics will contribute with its modelling expertise in biological systems\nperforming simulations of mutual interest.\n\nDr Christophe Chassagnole, COO of Physiomics, said:\n\n\n'Physiomics has continued to develop its technology to the point where more\npowerful computer facilities were required. The team has already run some pilot\nstudies using the ILS 'Blue C' supercomputer and have demonstrated its potential\nto reduce tasks that would take many hours to complete, to just a couple of\nminutes. As well the research collaborations with the ILS' research teams will\ngive us access to invaluable expertise and experimental data in the oncology\nfield'.\n\n\nDavid Lewis, Director of the Blue C facility at Swansea University's ILS, said:\n\n'We are delighted to enter a very constructive Collaborative Research agreement\nwith Physiomics. Our ILS project is funded (in part) by European Union\nStructural Funds, which are focussed on promoting Economic Development in West\nWales and the Valleys. Swansea University's School of Medicine, and the\nInstitute of Life Science, plays a k...